{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:13:38Z","timestamp":1778660018331,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jemermed.2012.11.104","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T21:00:56Z","timestamp":1368219656000},"page":"199-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Medical Outcomes Associated with Nonmedical Use of Methadone and Buprenorphine"],"prefix":"10.1016","volume":"45","author":[{"given":"Samantha","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Klein-Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Doyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2012.11.104_bib1","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1990\u22122008","volume":"60","author":"Paulozzi","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jemermed.2012.11.104_bib2","unstructured":"US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network. Available at: http:\/\/www.samhsa.gov\/data\/DAWN.aspx. Accessed June 17,\u00a02012."},{"key":"10.1016\/j.jemermed.2012.11.104_bib3","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","article-title":"Patterns of abuse among unintentional pharmaceutical overdose fatalities","volume":"300","author":"Hall","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2012.11.104_bib4","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"1-b","key":"10.1016\/j.jemermed.2012.11.104_bib5","first-page":"S14","article-title":"Opioid dependence treatment and guidelines","volume":"16","author":"Nicholls","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jemermed.2012.11.104_bib6","unstructured":"Drug Enforcement Administration Office of Diversion Control Controlled Substance Schedules. Available at: http:\/\/www.deadiversion.usdoj.gov\/schedules\/index.html#list. Accessed October 7,\u00a02011."},{"key":"10.1016\/j.jemermed.2012.11.104_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007691-200208000-00001","article-title":"Characterization of methadone overdose: clinical considerations and the scientific evidence","volume":"24","author":"Wolff","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jemermed.2012.11.104_bib8","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","article-title":"The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic","volume":"70","author":"Walsh","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jemermed.2012.11.104_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/02791072.2010.10400689","article-title":"Buprenorphine in the treatment of opiate dependence","volume":"42","author":"Wesson","year":"2010","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.jemermed.2012.11.104_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1521-0391.2010.00086.x","article-title":"Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment","volume":"19","author":"Maremmani","year":"2010","journal-title":"Am J Addict"},{"key":"10.1016\/j.jemermed.2012.11.104_bib11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction","volume":"35","author":"Jasinski","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jemermed.2012.11.104_bib12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jama.1947.02890140008003","article-title":"Tolerance and addiction liability of 6-dimethylamino-4-4-diphenylheptanonr-3 (methadone)","volume":"135","author":"Isbell","year":"1947","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2012.11.104_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jsat.2010.01.006","article-title":"Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment","volume":"38","author":"Megarbane","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jemermed.2012.11.104_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jemermed.2012.11.104_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1360-0443.2004.00790.x","article-title":"A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths","volume":"99","author":"Pirnay","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.jemermed.2012.11.104_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00228-010-0932-0","article-title":"Trends in opioid analgesics consumption, Israel 2000-2008","volume":"67","author":"Ponizovsky","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2012.11.104_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2011.04.002","article-title":"Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing","volume":"118","author":"Larance","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jemermed.2012.11.104_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1521-0391.2009.00008.x","article-title":"Indicators of buprenorphine and methadone use and abuse: what do we know?","volume":"19","author":"Maxwell","year":"2009","journal-title":"Am J Addict"},{"key":"10.1016\/j.jemermed.2012.11.104_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.annemergmed.2008.07.015","article-title":"The under recognized toll of prescription opioid abuse on young children","volume":"53","author":"Bailey","year":"2009","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2012.11.104_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v26n03_12","article-title":"Abuse of buprenorphine in the United States: 2003-2005","volume":"26","author":"Smith","year":"2007","journal-title":"J Addict Dis"},{"key":"10.1016\/j.jemermed.2012.11.104_bib21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1526-4637.2010.00877.x","article-title":"Post-marketing surveillance of methadone and buprenorphine in the United States","volume":"11","author":"Dasgupta","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.jemermed.2012.11.104_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1521-0391.2009.00002.x","article-title":"Methadone and buprenorphine toxicity in children","volume":"19","author":"Boyer","year":"2009","journal-title":"Am J Addict"},{"key":"10.1016\/j.jemermed.2012.11.104_bib23","unstructured":"Smith MY, Irish W, Wang J, Haddox JD, Dart RC. Relative rate of opioid analgesic abuse in communities in the US. The College on\u00a0Problems of Drug Dependence Conference. Scottsdale, AZ, June\u00a02006."},{"key":"10.1016\/j.jemermed.2012.11.104_bib24","unstructured":"Dart RC, Hughes AA, Smith MY. Reporting for the RADARS\u00ae System Poison Control Centers. Adolescent prescription opioid abuse and misuse: surveillance by poison centers. The College on Problems of Drug Dependence Conference, Scottsdale, AZ, June\u00a02006."},{"key":"10.1016\/j.jemermed.2012.11.104_bib25","unstructured":"Kirtland MN, Bailey JE, Dart RC. Prescription opioid associated death rates using RADARS\u00ae System Data. American Academy of\u00a0Addiction Psychiatry Conference, Boca Raton, FL, December\u00a02008."},{"key":"10.1016\/j.jemermed.2012.11.104_bib26","unstructured":"Campagna E, Bailey JE, Dart RC. Prescription opioid abuse in urban versus rural communities using RADARS\u00ae System Data. The College on Problems of Drug Dependence Conference, Quebec City, Canada, June,\u00a02007."},{"key":"10.1016\/j.jemermed.2012.11.104_bib27","unstructured":"Bailey JE, Cram L, Dart RC. Description of buprenorphine, methadone, hydrocodone and oxycodone abuse and diversion rates using RADARS\u00ae System Data. The College on Problems of Drug Dependence Conference, Quebec City, Canada, June\u00a02007."},{"key":"10.1016\/j.jemermed.2012.11.104_bib28","series-title":"Characterization of buprenorphine abuse using RADARS\u00ae System Poison Center Data. The College on Problems of Drug Dependence Annual Meeting","author":"Spaeth","year":"2008"},{"key":"10.1016\/j.jemermed.2012.11.104_bib29","unstructured":"Montoya AM, Heltshe SL, Dart RC. Spatial analysis of RADARS\u00ae System Data to identify geographic hot spots of prescription opioid abuse. The College on Problems of Drug Dependence Conference, San Juan, Puerto Rico, June\u00a02008."},{"key":"10.1016\/j.jemermed.2012.11.104_bib30","unstructured":"Spiller HA, Lorenz D, Bailey JE, Dart RC. Epidemiological trends in prescription drug misuse and abuse. The College on Problems of Drug Dependence Annual Meeting. San Juan, Puerto Rico, June\u00a02008."},{"key":"10.1016\/j.jemermed.2012.11.104_bib31","unstructured":"The Researched Abuse, Diversion and Addiction-Related Surveillance System. RADARS Third Quarter Newsletter 2011;6(3). Available at: http:\/\/www.radars.org\/Portals\/1\/RADARS_System_3Q2011_Newsletter.pdf. Accessed August\u00a02011."},{"key":"10.1016\/j.jemermed.2012.11.104_bib32","unstructured":"Buprenorphine diversion may signal need for more MAT and greater oversight. Addiction treatment forum. Available at: http:\/\/atforum.com\/news\/2011\/08\/buprenorphine-diversion\/. Accessed September\u00a02011."},{"key":"10.1016\/j.jemermed.2012.11.104_bib33","unstructured":"Niblock M. Suboxone abuse rears its head. Available at: http:\/\/portlanddailysun.me\/node\/25261. Accessed September\u00a02011."},{"key":"10.1016\/j.jemermed.2012.11.104_bib34","unstructured":"University of Maryland, College Park Center for Substance Abuse Research. Buprenorphine availability, diversion, and misuse: a summary of the CESAR FAX Series 2011;20(28). Available at: http:\/\/www.cesar.umd.edu\/cesar\/cesarfax.asp. Accessed August\u00a02011."},{"key":"10.1016\/j.jemermed.2012.11.104_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/15563650.2010.543906","article-title":"2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report","volume":"48","author":"Bronstein","year":"2010","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jemermed.2012.11.104_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.annemergmed.2011.08.004","article-title":"Using poison center data for national public health surveillance for chemical and poison exposure and associated illness","volume":"59","author":"Wolkin","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2012.11.104_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.jemermed.2012.11.104_bib38","unstructured":"NPDS Annual Report Terminology. American Association of Poison Control Centers. Available at: http:\/\/www.aapcc.org\/dnn\/NewsandEvents\/NewsMediaResources\/NPDSAnnualReportTerminology.aspx. Accessed July 29,\u00a02011."},{"key":"10.1016\/j.jemermed.2012.11.104_bib39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","volume":"18","author":"Mitchell","year":"2009","journal-title":"Am J Addict"},{"key":"10.1016\/j.jemermed.2012.11.104_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"J Addict Med"},{"key":"10.1016\/j.jemermed.2012.11.104_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.15288\/jsad.2011.72.774","article-title":"Hospitalizations for alcohol and drug overdoses in young adults ages 18-24 in the United States, 1999-2008: results from the nationwide inpatient sample","volume":"72","author":"White","year":"2011","journal-title":"J Stud Alcohol Drugs"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467913001376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467913001376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:28:43Z","timestamp":1760027323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467913001376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0736467913001376"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2012.11.104","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Outcomes Associated with Nonmedical Use of Methadone and Buprenorphine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2012.11.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}